Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF) - Concepedia

Concepedia

Publication | Open Access

Treatment with IL-17 prolongs the half-life of chemokine CXCL1 mRNA via the adaptor TRAF5 and the splicing-regulatory factor SF2 (ASF)

DOI Full Paper Access

219

Citations

34

References

2011

Year

Dongxu Sun, Michael Novotny, Katarzyna Bulek, Caini Liu, Xiaoxia Li, Thomas A. Hamilton

Nature Immunology

InflammationIl-17 ProlongsCytokineSplicing-regulatory Factor Sf2Adaptor Traf5ImmunologyImmune RegulationChronic InflammationImmune SurveillanceAutoimmunityImmune MediatorImmunotherapyMedicineCell BiologyCell SignalingTumor Microenvironment

References

	Year	Citations

Page 1

Page 1